Send us a link
Nation prevented far more in medical spending and lost productivity than it spent on testing, buying & delivering the 2021 vaccines
Study on hydroxychloroquine by Didier Raoult and colleagues gets pulled on ethical and scientific grounds
Policymakers should communicate how science informs their values and priorities in weighing policy trade-offs.
During the coronavirus disease 2019 pandemic, Facebook began to remove vaccine misinformation as a matter of policy. This study evaluated the efficacy of these policies using a comparative interrupted time-series design.
This paper studies the national implementation, in Finland, of the European Union (EU) programme for COVID-19 recovery, the Recovery and Resilience Facility (RRF), as an example of a cross-sectoral policy programme.
Although the acute phase of the pandemic may be over, experts agree that the virus's effects will remain profound
A recent article in the Israel Journal of Health Policy Research (IJHPR), analyzes the factors behind a recent surge in high quality publications by Israeli researchers, which have also informed global efforts to control the COVID-19 pandemic. This blog highlights two of those factors which may be particularly relevant for researchers, research institutions, and research authorities in other countries.
In the first nationally representative survey of U.S. adults on reasons for trust in federal, state, and local public health agencies' information during the COVID-19 pandemic, researchers found that the Centers for Disease Control and Prevention (CDC) was highly trusted for information by more than one-third of U.S. adults, whereas state and local health departments were highly trusted by about one-quarter.
New technologies might provide more potent or broader immunity - but will have to fight for market share.
This meta-analysis of 42 studies finds that learning progress has slowed during the coronavirus disease 2019 pandemic, particularly among children from low socio-economic backgrounds and in poorer countries. Reported learning deficits were larger in maths than in reading.
What role did science play in managing the Covid-19 pandemic from January to December 2020? In what way did the Swiss experience differ from selected other countries? Where is there a need for action in the future?
In recent weeks, the European Commission outlined its health strategy and the steps needed to be in a better position to tackle future health emergencies.
The COVID-19 pandemic prompted many discussions about how people's trust in science shaped our ability to address the crisis. Early in the pandemic, our research team set out to understand how trust in science relates to support for public health guidelines, and to identify some trusted sources of science. In this essay, we share our findings and offer ideas about what might be done to strengthen the public's trust in science. Notably, our research shows a stark partisan divide: Republicans had lower support for public health guidelines, and their trust in science and institutions such as the Centers for Disease Control and Prevention and the National Institutes of Health eroded over time. Meanwhile, Democrats' trust in science has remained high throughout the pandemic. In the context of this divide, we explore how trust in various information sources, from governmental institutions to the media, relates to trust in science, and suggest that the best avenue for rebuilding trust might be through empowering local institutions and leaders to help manage future crises.
Based on a survey of over 3000 researchers worldwide, Economist Impact identified important actions that should be considered if mistakes are not to be repeated during future health emergencies.
An ongoing narrative seeks to shift the blame away from the government for mismanagement of the pandemic, by depicting it as beholden to all-powerful scientists.
